J B Chemicals Pharmaceuticals has received ANDA approval from the USFDA for Venlafaxine Extended Release Tablets 375mg 75mg 150mg and 225mg This product is based on OROS Osmotic Controlled Release Oral Delivery System technology an advanced and precision-controlled release mechanism The generic product approval is bioequivalent and therapeutically equivalent to the reference listed drug RLD Venlafaxine Hydrochloride Extended-Release Tablets 375 mg 75 mg 150 mg and 225 mg of Osmotica Pharmaceutical US LLC As per IQVIA Health MAT Oct 2022 data Venlafaxine Extended-Release tablets recorded annualized sales of approximately $ 48 million in the US
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.